BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31566876)

  • 1. United States donation after circulatory death liver transplantation is driven by a few high-utilization transplant centers.
    Hobeika MJ; Menser T; Nguyen DT; Beal LL; Zajac S; Graviss EA
    Am J Transplant; 2020 Jan; 20(1):320-321. PubMed ID: 31566876
    [No Abstract]   [Full Text] [Related]  

  • 2. The Current State of Liver Transplantation in the United States: Perspective From American Society of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTS Council.
    Fayek SA; Quintini C; Chavin KD; Marsh CL
    Am J Transplant; 2016 Nov; 16(11):3093-3104. PubMed ID: 27545282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States.
    Mooney JJ; Hedlin H; Mohabir PK; Vazquez R; Nguyen J; Ha R; Chiu P; Patel K; Zamora MR; Weill D; Nicolls MR; Dhillon GS
    Am J Transplant; 2016 Apr; 16(4):1207-15. PubMed ID: 26844673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again.
    Cascales-Campos PA; Ferreras D; Alconchel F; Febrero B; Royo-Villanova M; Martínez M; Rodríguez JM; Fernández-Hernández JÁ; Ríos A; Pons JA; Sánchez-Bueno F; Robles R; Martínez-Barba E; Martínez-Alarcón L; Parrilla P; Ramírez P
    Am J Transplant; 2020 Jan; 20(1):204-212. PubMed ID: 31329359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.
    Scalea JR; Redfield RR; Arpali E; Leverson GE; Bennett RJ; Anderson ME; Kaufman DB; Fernandez LA; D'Alessandro AM; Foley DP; Mezrich JD
    Am J Transplant; 2017 Jan; 17(1):191-200. PubMed ID: 27375072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement.
    Croome KP; Daneshmand MA
    Am J Transplant; 2021 Feb; 21(2):484-487. PubMed ID: 32956516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noneligible Donors as a Strategy to Decrease the Organ Shortage.
    Croome KP; Lee DD; Keaveny AP; Taner CB
    Am J Transplant; 2017 Jun; 17(6):1649-1655. PubMed ID: 27977900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a National Controlled Donation After Circulatory Death (DCD) Program on Organ Donation in the United Kingdom: A 10-Year Study.
    Hodgson R; Young AL; Attia MA; Lodge JPA
    Am J Transplant; 2017 Dec; 17(12):3172-3182. PubMed ID: 28556608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agree on much, except it is time for change.
    Samstein B; McElroy LM
    Am J Transplant; 2019 Jul; 19(7):1912-1916. PubMed ID: 30884119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPTN/SRTR 2017 Annual Data Report: Deceased Organ Donation.
    Israni AK; Zaun D; Rosendale JD; Schaffhausen C; Snyder JJ; Kasiske BL
    Am J Transplant; 2019 Feb; 19 Suppl 2():485-516. PubMed ID: 30811886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of incorporating standardized, verifiable, objective metrics of organ procurement organization performance into discussions about organ allocation.
    Goldberg D; Karp S; Shah MB; Dubay D; Lynch R
    Am J Transplant; 2019 Nov; 19(11):2973-2978. PubMed ID: 31199562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donation after circulatory death donor allografts on outcomes following liver transplantation for fulminant hepatic failure in the United States.
    Kumar S; Lin S; Schold JD
    Am J Transplant; 2021 Jan; 21(1):382-390. PubMed ID: 32865321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to "Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again".
    Cascales-Campos PA; Ferreras D; Alconchel F; Febrero B; Royo-Villanova M; Martínez M; Rodríguez JM; Fernández-Hernández JÁ; Ríos A; Pons JA; Sánchez-Bueno F; Robles R; Martínez-Barba E; Martínez-Alarcón L; Parrilla P; Ramírez P
    Am J Transplant; 2020 Feb; 20(2):615-616. PubMed ID: 31665551
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Croome KP; Mathur AK; Lee DD; Moss AA; Rosen CB; Heimbach JK; Taner CB
    Transplantation; 2018 Jul; 102(7):1108-1114. PubMed ID: 29952924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we mitigate the effects of simultaneous liver-kidney transplantation through increased utilization of HCV-positive donors?
    Sibulesky L; Perkins JD; Landis CS; Johnson CK
    Am J Transplant; 2018 Oct; 18(10):2604-2605. PubMed ID: 30102461
    [No Abstract]   [Full Text] [Related]  

  • 16. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
    Selck FW; Grossman EB; Ratner LE; Renz JF
    Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers.
    Miñambres E; Ruiz P; Ballesteros MA; Álvarez C; Cifrián JM; Atutxa L; Ventoso A; Castillo F; Gastaca M
    Am J Transplant; 2020 Jan; 20(1):231-240. PubMed ID: 31265753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobile ECMO team for controlled donation after circulatory death.
    Pérez-Villares JM; Lara-Rosales R; Fernández-Carmona A; Fuentes-Garcia P; Burgos-Fuentes M; Baquedano-Fernández B
    Am J Transplant; 2018 May; 18(5):1293-1294. PubMed ID: 29316269
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the procurement surgeon on transplanted abdominal organ outcomes: An SRTR analysis to evaluate regional organ procurement collaboration.
    Serrano OK; Vock DM; Snyder JJ; Chinnakotla S; Kandaswamy R; Pruett TL; Matas AJ; Finger EB
    Am J Transplant; 2019 Aug; 19(8):2219-2231. PubMed ID: 30748093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OPTN Deceased Donor Potential Study: Implications for Policy and Practice.
    Klassen DK; Edwards LB; Stewart DE; Glazier AK; Orlowski JP; Berg CL
    Am J Transplant; 2016 Jun; 16(6):1707-14. PubMed ID: 26813036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.